Tags

Type your tag names separated by a space and hit enter

Risk and course of motor complications in a population-based incident Parkinson's disease cohort.
Parkinsonism Relat Disord. 2016 Jan; 22:48-53.PR

Abstract

BACKGROUND

Motor complications may become major challenges in the management of patients with Parkinson's disease. In this study, we sought to determine the incidence, risk factors, evolution, and treatment of motor fluctuations and dyskinesias in a population-representative, incident Parkinson's disease cohort.

METHODS

In this prospective population-based 5-year longitudinal study, we followed 189 incident and initially drug-naïve Parkinson's disease patients biannually for detailed examination of dyskinesias and motor fluctuations as defined by the Unified Parkinson's disease Rating Scale. We performed Kaplan-Meier survival and Cox regression analyses to assess cumulative incidence and risk factors of these motor complications.

RESULTS

The 5-year cumulative incidence of motor complications was 52.4%. Motor fluctuations occurred in 42.9% and dyskinesias in 24.3%. Besides higher motor severity predicting both motor fluctuations (p = 0.016) and dyskinesias (p < 0.001), lower age at diagnosis predicted motor fluctuations (p = 0.001), whereas female gender predicted dyskinesias (p = 0.001). Actual levodopa dose at onset of motor fluctuations (p = 0.037) or dyskinesias (p < 0.001) rather than initial treatment with levodopa (p > 0.1) independently predicted development of motor complications. Motor fluctuations reversed in 37% and dyskinesias in 49% of patients on oral treatment and remained generally mild in those with persistent complications. No patients received device-aided therapies during the study.

CONCLUSIONS

More than 50% in the general Parkinson's disease population develop motor complications within 5 years of diagnosis. However, they remain mild in the vast majority and are reversible in a substantial proportion of patients.

Authors+Show Affiliations

The Norwegian Centre for Movement Disorders, Stavanger University Hospital, PO Box 8100, N-4068 Stavanger, Norway; Department of Neurology, Stavanger University Hospital, Stavanger, Norway. Electronic address: anders.bjornestad@outlook.com.The Norwegian Centre for Movement Disorders, Stavanger University Hospital, PO Box 8100, N-4068 Stavanger, Norway; Department of Neurology, Stavanger University Hospital, Stavanger, Norway. Electronic address: elin.bjelland.forsaa@sus.no.The Norwegian Centre for Movement Disorders, Stavanger University Hospital, PO Box 8100, N-4068 Stavanger, Norway; Department of Neurology, Stavanger University Hospital, Stavanger, Norway. Electronic address: kenn.freddy.pedersen@sus.no.Department of Neurology, Haukeland University Hospital, PO Box 1400, N-5021 Bergen, Norway; Institute of Clinical Medicine, University of Bergen, Norway. Electronic address: ole-bjorn.tysnes@helse-bergen.no.The Norwegian Centre for Movement Disorders, Stavanger University Hospital, PO Box 8100, N-4068 Stavanger, Norway. Electronic address: jpl@sus.no.The Norwegian Centre for Movement Disorders, Stavanger University Hospital, PO Box 8100, N-4068 Stavanger, Norway; Department of Neurology, Stavanger University Hospital, Stavanger, Norway. Electronic address: algu@sus.no.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

26585090

Citation

Bjornestad, Anders, et al. "Risk and Course of Motor Complications in a Population-based Incident Parkinson's Disease Cohort." Parkinsonism & Related Disorders, vol. 22, 2016, pp. 48-53.
Bjornestad A, Forsaa EB, Pedersen KF, et al. Risk and course of motor complications in a population-based incident Parkinson's disease cohort. Parkinsonism Relat Disord. 2016;22:48-53.
Bjornestad, A., Forsaa, E. B., Pedersen, K. F., Tysnes, O. B., Larsen, J. P., & Alves, G. (2016). Risk and course of motor complications in a population-based incident Parkinson's disease cohort. Parkinsonism & Related Disorders, 22, 48-53. https://doi.org/10.1016/j.parkreldis.2015.11.007
Bjornestad A, et al. Risk and Course of Motor Complications in a Population-based Incident Parkinson's Disease Cohort. Parkinsonism Relat Disord. 2016;22:48-53. PubMed PMID: 26585090.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Risk and course of motor complications in a population-based incident Parkinson's disease cohort. AU - Bjornestad,Anders, AU - Forsaa,Elin B, AU - Pedersen,Kenn Freddy, AU - Tysnes,Ole-Bjorn, AU - Larsen,Jan Petter, AU - Alves,Guido, Y1 - 2015/11/06/ PY - 2015/09/03/received PY - 2015/10/09/revised PY - 2015/11/02/accepted PY - 2015/11/21/entrez PY - 2015/11/21/pubmed PY - 2016/9/27/medline KW - Dyskinesias KW - Motor complications KW - Motor fluctuations KW - Parkinson's disease KW - Risk factors SP - 48 EP - 53 JF - Parkinsonism & related disorders JO - Parkinsonism Relat Disord VL - 22 N2 - BACKGROUND: Motor complications may become major challenges in the management of patients with Parkinson's disease. In this study, we sought to determine the incidence, risk factors, evolution, and treatment of motor fluctuations and dyskinesias in a population-representative, incident Parkinson's disease cohort. METHODS: In this prospective population-based 5-year longitudinal study, we followed 189 incident and initially drug-naïve Parkinson's disease patients biannually for detailed examination of dyskinesias and motor fluctuations as defined by the Unified Parkinson's disease Rating Scale. We performed Kaplan-Meier survival and Cox regression analyses to assess cumulative incidence and risk factors of these motor complications. RESULTS: The 5-year cumulative incidence of motor complications was 52.4%. Motor fluctuations occurred in 42.9% and dyskinesias in 24.3%. Besides higher motor severity predicting both motor fluctuations (p = 0.016) and dyskinesias (p < 0.001), lower age at diagnosis predicted motor fluctuations (p = 0.001), whereas female gender predicted dyskinesias (p = 0.001). Actual levodopa dose at onset of motor fluctuations (p = 0.037) or dyskinesias (p < 0.001) rather than initial treatment with levodopa (p > 0.1) independently predicted development of motor complications. Motor fluctuations reversed in 37% and dyskinesias in 49% of patients on oral treatment and remained generally mild in those with persistent complications. No patients received device-aided therapies during the study. CONCLUSIONS: More than 50% in the general Parkinson's disease population develop motor complications within 5 years of diagnosis. However, they remain mild in the vast majority and are reversible in a substantial proportion of patients. SN - 1873-5126 UR - https://www.unboundmedicine.com/medline/citation/26585090/Risk_and_course_of_motor_complications_in_a_population_based_incident_Parkinson's_disease_cohort_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1353-8020(15)30030-4 DB - PRIME DP - Unbound Medicine ER -